Trivarx Ltd has released a press release.
Phase 1 Trial Completed for SAMDE Study
Filed with ASX ·
6ix hasn’t read this filing yet.
Story so far
Earlier from TrivarX
- Medibio Completes Share Purchase Plan
- March 2023 Quarterly Activities Report and Appendix 4C
- MEB Executes Bridging Loans with Directors
- Share Purchase Plan Supplementary Prospectus
- Share Purchase Plan Prospectus
Later from TrivarX
- June 2023 Quarterly Activities Report and Appendix 4C
- Medibio Receives Firm Commitments to Raise $2.25m
- Proposed issue of securities - MEB
- Phase 2 Trial Commences for SAMDE Study
- Letter to Shareholders & Notice of GM & Proxy Form
Follow TrivarX into a list and get an email when it puts out news.
Follow TrivarX